FAKTOR-OPTIONSSCHEIN - JOHNSON & JOHNSON Share Price

Certificat

DE000SU1H5A5

Market Closed - Deutsche Boerse AG 20:47:38 17/05/2024 BST
6.55 EUR +3.80% Intraday chart for FAKTOR-OPTIONSSCHEIN - JOHNSON & JOHNSON
Current month+71.02%
1 month+66.67%
Date Price Change
17/05/24 6.55 +3.80%
16/05/24 6.31 +9.74%
15/05/24 5.75 +7.88%
14/05/24 5.33 +2.11%
13/05/24 5.22 +5.24%

Delayed Quote Deutsche Boerse AG

Last update May 17, 2024 at 08:47 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer Société Générale Société Générale
WKN SU1H5A
ISINDE000SU1H5A5
Date issued 02/11/2023
Strike 148.3 $
Maturity Unlimited
Parity 1 : 1
Emission price 10.38
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 18.56
Lowest since issue 3.71
Spread 0.05
Spread %0.75%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
154.6 USD
Average target price
173.3 USD
Spread / Average Target
+12.04%
Consensus